IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2017 Donato Perez Garcia.



Thursday, February 11, 2010

IPT is one cancer therapy that the medical establishment is not depriving from patients

In general terms the "medical establishment" does not deprive cancer patients from seeking a treatment.
IPT and IPTLD have been presented at the NIH for a Best Case presentation. You can read the minutes of that meeting in the Archives of the NIH September 18 ,2000. One thing I can say: IPT was not turned away, needs more clinical trials. The prescription drugs - chemo drugs - are all FDA approved. Only medical doctors can administer IPT and there is a basic training for the interested physicians.
IPTLD / IPT is a treatment alternative.

No comments: